Clinical findings, diagnostic approach, and outcome of Brucella melitensis epididymo-orchitis

被引:41
作者
Colmenero, Juan D.
Munoz-Roca, Nuria L.
Bermudez, Pilar
Plata, Antonio
Villalobos, Aurora
Reguera, Jose M.
机构
[1] Hosp Univ Carlos Haya, Serv Enfermedades Infecc, Malaga 29010, Spain
[2] Hosp Univ Carlos Haya, Microbiol Serv, Malaga 29010, Spain
关键词
brucellosis; epididymo-orchitis;
D O I
10.1016/j.diagmicrobio.2006.09.008
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We have studied 912 patients with brucellosis. Of these, 631 (69.2%) were inale and 48 had epididymo-orchitis, giving an incidence of epididymo-orchitis of 7.6%. The duration of symptoms before diagnosis was 52.5 + 70 days. All the patients had fever, swelling, and scrotal pain, but only 2 (4.2%) reported urinary symptoms. Seven patients (14.5%) had leukocyte figures above 11 x 109/L, and urine analysis was normal in 69% of the patients. Blood cultures were positive in 65.8% of cases. A total of 33 patients (68.8%) received a combination of doxycycline plus streptomycin and 13 (27. 1%) doxycycline plus rifampin. The overall percentage of failure or relapse was 8.8%: 7.1 % in the doxycycline plus streptomycin group and 20% in the doxycycline plus rifampin group. None of the patients required surgery. Pending clinical trials to confirm the results, conservative management with a combination of doxycycline for 2 months and streptomycin for 14 to 21 days appears to be adequate and could avoid unnecessary orchiectomy. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:367 / 372
页数:6
相关论文
共 36 条
  • [1] Alton G. G., 1975, LAB TECHNIQUES BRUCE
  • [2] ARIZA J, 1985, REV INFECT DIS, V7, P656
  • [3] SPECIFIC ANTIBODY PROFILE IN HUMAN BRUCELLOSIS
    ARIZA, J
    PELLICER, T
    PALLARES, R
    FOZ, A
    GUDIOL, F
    [J]. CLINICAL INFECTIOUS DISEASES, 1992, 14 (01) : 131 - 140
  • [4] CHARACTERISTICS OF AND RISK-FACTORS FOR RELAPSE OF BRUCELLOSIS IN HUMANS
    ARIZA, J
    CORREDOIRA, J
    PALLARES, R
    VILADRICH, PF
    RUFI, G
    PUJOL, M
    GUDIOL, F
    [J]. CLINICAL INFECTIOUS DISEASES, 1995, 20 (05) : 1241 - 1249
  • [5] TREATMENT OF HUMAN BRUCELLOSIS WITH DOXYCYCLINE PLUS RIFAMPIN OR DOXYCYCLINE PLUS STREPTOMYCIN - A RANDOMIZED, DOUBLE-BLIND-STUDY
    ARIZA, J
    GUDIOL, F
    PALLARES, R
    VILADRICH, PF
    RUFI, G
    CORREDOIRA, J
    MIRAVITLLES, MR
    [J]. ANNALS OF INTERNAL MEDICINE, 1992, 117 (01) : 25 - 30
  • [6] BRUCELLAR SACROILIITIS - FINDINGS IN 63 EPISODES AND CURRENT RELEVANCE
    ARIZA, J
    PUJOL, M
    VALVERDE, J
    NOLLA, JM
    RUFI, G
    VILADRICH, PF
    CORREDOIRA, JM
    GUDIOL, F
    [J]. CLINICAL INFECTIOUS DISEASES, 1993, 16 (06) : 761 - 765
  • [7] BRUCELLOSIS IN A GROUP OF TRAVELERS TO SPAIN
    ARNOW, PM
    SMARON, M
    ORMISTE, V
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 251 (04): : 505 - 507
  • [8] Bayram MM, 1997, J CLIN ULTRASOUND, V25, P443, DOI 10.1002/(SICI)1097-0096(199710)25:8<443::AID-JCU6>3.0.CO
  • [9] 2-J
  • [10] Castillo Soria J L, 1994, Arch Esp Urol, V47, P533